BioCentury
ARTICLE | Clinical News

Micardis telmisartan: Phase IV data

April 7, 2008 7:00 AM UTC

In the double-blind, international Phase IV ONTARGET trial in 25,620 high-risk cardiovascular patients, the 56-month rate of cardiovascular death, myocardial infarction, stroke and hospitalization for...